Company news
Blau Farmaceutica Sa (BMFBOVESPA:BLAU3) news
Blau Farmaceutica Sa news releases on 6ix. Latest, May 8, 2026: Blau Farmacêutica: 33% revenue growth and margin expansion in 1Q26, with zero leverage…
Press releases & updates
Blau Farmacêutica: 33% revenue growth and margin expansion in 1Q26, with zero leverage and strong cash position
May 8, 2026
Blau Farmacêutica: Biosimilars and mAbs drive transformational growth, supported by expansion and innovation
April 7, 2026
Blau Farmacêutica: Record biotech investment and margin gains offset revenue dip; outlook for 2026 is strong
March 18, 2026
Blau Farmacêutica: Net income jumped 52% on stable revenue, margin gains, and divestment proceeds
November 4, 2025
Blau Farmacêutica: Gross margin and EBITDA hit record levels as capacity expansion and pipeline drive future growth
August 6, 2025
Blau Farmacêutica: Q1 2025 saw 4% revenue growth, 50% higher net income, and strong private hospital performance
May 7, 2025
Blau Farmacêutica: Record net income and margin gains in 2024, with strong growth in all core segments
March 19, 2025
Blau Farmacêutica: Record revenue, margin gains, and cash flow highlight Blau's strong 3Q24 performance
November 6, 2024
Blau Farmacêutica: Record Q2 revenue and margin gains fueled by private market growth and operational efficiency
August 7, 2024